Loading...
Treatment of HER2-positive Breast Cancer
The human epidermal growth factor receptor 2 gene (HER2) is overexpressed and/or amplified in ~ 15% of breast cancer patients and was identified a quarter century ago as a marker of poor prognosis. By 1998, antibody therapy targeting the HER2 pathway was shown to demonstrably improve progression-fre...
Na minha lista:
| Udgivet i: | Breast |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4466908/ https://ncbi.nlm.nih.gov/pubmed/24360619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2013.11.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|